NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/27/2026
Back to search
Official data from USPTO
OPDIVO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
57
Latest update
04/21/2026
Trademark type
Combined
Nice classes
5
Filing date
01/24/2014
Registration date
03/08/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/27/2026
Last transaction
04/21/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/06/2015
First use in commerce
07/06/2015
Drawing code
3
Owner type
03
Owner location
Princeton, NJ, US
Examiner
BUSH, KAREN K
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "OPDIVO" in stylized font with a diagonal double slash design appearing below the first "O" and above the "V".
Holders and representatives
Holders
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company
Representatives
Marilyn F. Kelly Bristol-Myers Squibb Company
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for human use for the treatment and prevention of obesitydiabetesincontinencecardiovascular diseasescentral nervous system diseases and disordersmetabolic disordersstrokecancerinflammation and inflammatory diseasesrespiratory and infectious diseasesauto-immune diseasessolid organ transplant rejection; pharmaceutical preparations for human useantibioticsanti-fungalsanti-viralsimmunosuppressants and pharmaceutical antibodies
Publications
History of USPTO decisions and trademark events.
57 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/27/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/27/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/27/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
01/15/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/08/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/02/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/02/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/02/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/02/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/02/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/19/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/19/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/19/2022
E815
TEAS SECTION 8 & 15 RECEIVED
02/28/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/08/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/08/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/08/2018
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
06/06/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/23/2016
ES7R
TEAS SECTION 7 REQUEST RECEIVED
03/22/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
03/08/2016
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/03/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/02/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/30/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/30/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/29/2016
EEXT
SOU TEAS EXTENSION RECEIVED
01/27/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/15/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/14/2015
GNRT
NON-FINAL ACTION E-MAILED
08/14/2015
CNRT
SU - NON-FINAL ACTION - WRITTEN
08/14/2015
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/14/2015
EX1G
SOU EXTENSION 1 GRANTED
08/14/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/14/2015
IUAF
USE AMENDMENT FILED
07/27/2015
EXT1
SOU EXTENSION 1 FILED
07/27/2015
EEXT
SOU TEAS EXTENSION RECEIVED
07/27/2015
EISU
TEAS STATEMENT OF USE RECEIVED
07/27/2015
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/27/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/02/2014
PUBO
PUBLISHED FOR OPPOSITION
12/02/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/12/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/29/2014
ALIE
ASSIGNED TO LIE
10/29/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/09/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/08/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/07/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/07/2014
DOCK
ASSIGNED TO EXAMINER
07/01/2014
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
04/07/2014
GPRA
PRIORITY ACTION E-MAILED
04/07/2014
CPRA
PRIORITY ACTION WRITTEN
04/07/2014
DOCK
ASSIGNED TO EXAMINER
04/02/2014
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/06/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/05/2014
NWAP
NEW APPLICATION ENTERED
01/28/2014
Continuous trademark protection
Get notified about every new filing that threatens OPDIVO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.